Sign in

    Matthew Kress

    Research Analyst at Private Investor

    Matthew Kress is an investment analyst whose publicly available information is limited, with no direct evidence of current employment as an analyst at Private Investor. There is no record of a LinkedIn profile, documented coverage of specific companies, published performance rankings, or verifiable professional credentials such as securities licenses or FINRA registration. While his name appears in relation to financial discussions, such as educational content on digital assets, there is no substantiated track record of career milestones, analyst performance, or specific areas of sector specialization. Due to a lack of authoritative data, no comprehensive or metric-supported professional profile for Matthew Kress in this role can be accurately provided.

    Matthew Kress's questions to PURE BIOSCIENCE (PURE) leadership

    Matthew Kress's questions to PURE BIOSCIENCE (PURE) leadership • Q1 2019

    Question

    Matthew Kress, a private investor, asked if the company logically projects it will be profitable by the end of the following year, considering the current 124% quarterly revenue growth and the target for cash flow breakeven.

    Answer

    VP of Finance Mark Elliott affirmed that achieving the cash flow breakeven run rate is a logical expectation. He specified that this projection is based on the anticipated business from Taylor Farms, combined with current and expected margins.

    Ask Fintool Equity Research AI